Vireo Growth (VREOF) Current Deferred Revenue (2020 - 2026)

Vireo Growth's (VREOF) quarterly Current Deferred Revenue came in at $4.3 million in Q1 2026, up 260.28% year-on-year from $1.2 million in Q1 2025, and down 8.51% quarter-over-quarter from $4.7 million in Q4 2025.

Vireo Growth (VREOF) Current Deferred Revenue (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Current Deferred Revenue across 7 years of filings, most recently posting $4.3 million for Q1 2026.

  • Current Deferred Revenue for Q1 2026 came in at $4.3 million, up 260.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 million (up 260.28% YoY), and the FY2025 annual result was $4.7 million, up 346.07% from the prior year.
  • Current Deferred Revenue came in at $4.3 million for Q1 2026 at Vireo Growth, down from $4.7 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $4.7 million in Q4 2025 to a low of $450334.0 in Q1 2022.
  • The 5-year median for Current Deferred Revenue is $833832.0 (2023), against an average of $1.4 million.
  • Across the five-year window, Current Deferred Revenue increased 13.22% in 2023 and surged 346.07% in 2025, its largest moves.
  • Vireo Growth's Current Deferred Revenue stood at $684703.0 in 2022, then advanced by 21.78% to $833832.0 in 2023, then climbed by 26.36% to $1.1 million in 2024, then soared by 346.07% to $4.7 million in 2025, then retreated by 8.51% to $4.3 million in 2026.
  • The last three Current Deferred Revenue figures came in at $4.3 million (Q1 2026), $4.7 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Vireo Growth - - 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.30 Mn
Dec 31, 2025 4.70 Mn
Sep 30, 2025 2.46 Mn
Jun 30, 2025 2.43 Mn
Mar 31, 2025 1.19 Mn
Dec 31, 2024 1.05 Mn
Sep 30, 2024 921,785.00
Jun 30, 2024 821,761.00
Mar 31, 2024 885,696.00
Dec 31, 2023 833,832.00
Sep 30, 2023 732,775.00
Jun 30, 2023 626,689.00
Mar 31, 2023 710,117.00
Dec 31, 2022 684,703.00
Sep 30, 2022 647,208.00
Jun 30, 2022 522,926.00
Mar 31, 2022 450,334.00
Dec 31, 2021 409,627.00
Sep 30, 2021 424,448.00
Jun 30, 2021 374,498.00